Covid-19 - kortikosteroidbehandling vid svår sjukdom : En jämförande analys

Covid-19 - kortikosteroidbehandling vid svår sjukdom : En jämförande analys

Sammanfattning Sedan sjukdomen Covid-19s uppdykande i början av 2020 har forskning pågått för att karaktärisera sjukdomen ur alla tänkbara vinklar för att på kortast möjliga tid bereda väg för ett fungerande botemedel. Effektiva läkemedel som kan minska risken för allvarligt sjuka patienter att avli...

Full description

Bibliographic Details
Main Author:	Woin, Nicolas
Format:	Others
Language:	Swedish
Published:	Linnéuniversitetet, Institutionen för kemi och biomedicin (KOB) 2021
Subjects:	Covid-19 Sars-CoV-2 coronavirus corticosteroids glucocorticoids dexamethasone methylprednisolone hydrocortisone ARDS CARDS meta-analysis glukokortikoider dexametason metylprednisolon hydrokortison Social and Clinical Pharmacy Samhällsfarmaci och klinisk farmaci
Online Access:	http://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-100996

Similar Items

Recurrent SARS-CoV-2 infection resulting in acute respiratory distress syndrome and development of pulmonary hypertension: A case report
by: Sameena Salcin, et al.
Published: (2021-01-01)

Steroid therapy for COVID-19: A systematic review and meta-analysis of randomized controlled trials
by: Tarun Krishna Boppana, et al.
Published: (2021-07-01)

Corrigendum: Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused
by: Sachin Chaudhary, et al.
Published: (2021-03-01)

Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused
by: Sachin Chaudhary, et al.
Published: (2020-09-01)

Coronavirus Disease (Covid-19): What Are We Learning in a Country With High Mortality Rate?
by: Luciano Mutti, et al.
Published: (2020-05-01)

Post-COVID-19 Pulmonary Fibrosis: Novel Sequelae of the Current Pandemic
by: Shiva Rattan Ambardar, et al.
Published: (2021-06-01)

Benefits of Steroid Therapy in COVID-19 Patients with Different PaO<sub>2</sub>/FiO<sub>2</sub> Ratio at Admission
by: Serena Vita, et al.
Published: (2021-07-01)

Rapidly developing large pneumatocele and spontaneous pneumothorax in SARS-CoV-2 infection
by: Raghavendra R. Sanivarapu, MD, et al.
Published: (2020-01-01)

Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples
by: Richard S. Bennett, et al.
Published: (2021-05-01)

Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
by: Flavio A. Cadegiani, et al.
Published: (2020-07-01)

Long-Term Neurological Threats of COVID-19: A Call to Update the Thinking About the Outcomes of the Coronavirus Pandemic
by: Antonio Pereira
Published: (2020-04-01)

Doxycycline: From Ocular Rosacea to COVID-19 Anosmia. New Insight Into the Coronavirus Outbreak
by: Chiara Bonzano, et al.
Published: (2020-05-01)

Acute Respiratory Distress Syndrome and Time to Weaning Off the Invasive Mechanical Ventilator among Patients with COVID-19 Pneumonia
by: Jose Bordon, et al.
Published: (2021-06-01)

Anti-IL6R role in treatment of COVID-19-related ARDS
by: Franco Maria Buonaguro, et al.
Published: (2020-04-01)

Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
by: Ulf Andersson, et al.
Published: (2020-05-01)

Clinical Risk Factors for Mortality Among Critically Ill Mexican Patients With COVID-19
by: Carmen M. Hernández-Cárdenas, et al.
Published: (2021-08-01)

Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS
by: Zhiheng Xu, et al.
Published: (2021-10-01)

Commentary: Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated With Coronavirus Disease-2019
by: Maurizio Bifulco, et al.
Published: (2021-04-01)

An appraisal of respiratory system compliance in mechanically ventilated covid-19 patients
by: Gianluigi Li Bassi, et al.
Published: (2021-06-01)

The SARS-CoV-2 outbreak from a one health perspective
by: Maged Gomaa Hemida, et al.
Published: (2020-12-01)

Immune system response during viral Infections: Immunomodulators, cytokine storm (CS) and Immunotherapeutics in COVID-19
by: Faheem Hyder Pottoo, et al.
Published: (2021-02-01)

Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals
by: Elaine C. Chen, et al.
Published: (2021-08-01)

KG-COVID-19: A Framework to Produce Customized Knowledge Graphs for COVID-19 Response
by: Justin T. Reese, et al.
Published: (2021-01-01)

Commentary: Origin and evolution of pathogenic coronaviruses
by: Shun Adachi, et al.
Published: (2020-04-01)

Coronavirus Antiviral Research Database (CoV-RDB): An Online Database Designed to Facilitate Comparisons between Candidate Anti-Coronavirus Compounds
by: Philip L Tzou, et al.
Published: (2020-09-01)

Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs
by: Ujjwal Neogi, et al.
Published: (2020-04-01)

Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-19
by: Kemmian D. Johnson, et al.
Published: (2020-08-01)

Comparative genomic analysis demonstrates that true reinfection following SARS-CoV-2 infection is possible
by: Eamon O Murchu, et al.
Published: (2021-06-01)

Therapeutic role of corticosteroids in COVID-19: a systematic review of registered clinical trials
by: Reshma Raju, et al.
Published: (2021-03-01)

Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence
by: Frank M. P. van Haren, et al.
Published: (2020-07-01)

COVID-19: Lung-Centric Immunothrombosis
by: Peter R. Kvietys, et al.
Published: (2021-06-01)

Neurological pathogenesis of SARS-CoV-2 (COVID-19): from virological features to clinical symptoms
by: Yoshitaka Kase, et al.
Published: (2021-05-01)

Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19
by: Rafael B. Polidoro, et al.
Published: (2020-06-01)

Is There a Link Between the Pathogenic Human Coronavirus Envelope Protein and Immunopathology? A Review of the Literature
by: Dewald Schoeman, et al.
Published: (2020-09-01)

Scrutinizing Coronaviruses Using Publicly Available Bioinformatic Tools: The Viral Structural Proteins as a Case Study
by: Sonia Beeckmans, et al.
Published: (2021-05-01)

Defusing COVID-19: Lessons Learned from a Century of Pandemics
by: Graciela Mujica, et al.
Published: (2020-11-01)

Chemokines and chemokine receptors during COVID-19 infection
by: Bariaa A. Khalil, et al.
Published: (2021-01-01)

How to follow-up a patient who received tocilizumab in severe COVID-19: a case report
by: Regina B. Podlasin, et al.
Published: (2020-08-01)

Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications
by: Ioannis P. Trougakos, et al.
Published: (2021-01-01)

Lung Surfactant for Pulmonary Barrier Restoration in Patients With COVID-19 Pneumonia
by: Ursula Mirastschijski, et al.
Published: (2020-05-01)